HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Amerifit Shoulders More Responsibility As DSM's "Conduit To The Consumer"

This article was originally published in The Tan Sheet

Executive Summary

Amerifit Brands launches its first products since Martek Biosciences acquired it, and executives expect continued expansion as DSM integrates the supplement marketer.

You may also be interested in...



Interview: Health & Wellness Investment Bank PCGA Prioritizes Supplement Innovation, Quality

Investment capital has followed the flood of consumer interest in the natural health and wellness market. Partnership Capital Growth Advisors was founded as an investment bank and financial advisor in 2005 to focus precisely on the "healthy, active and sustainable living" segment.

DSM Nutrition's Hamilton Sees Complementary Benefits In Martek Deal

Royal DSM N.V. strengthened its identity as a life and material sciences company in late 2010 with its $1.09 billion purchase of Martek Biosciences.

Martek Pursues Direct Consumer Access With Pending Acquisition Of Amerifit

Martek Biosciences' proposed acquisition of Amerifit Brands for $200 million would mark the omega-3 DHA ingredient supplier's first major foray into consumer marketing and would substantially expand the firm's portfolio

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS134159

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel